Ir al contenido

Latin America
Clinical Research
Sites Network

Endpoints is the Leading Network of Clinical Research Centers in Latin America. Sponsors and CROs trusted partner to deliver high-quality clinical, epidemiological, and public health research.

About Us

About Us

doctores

Accelerating Innovative Treatments and Driving Impact in Latin America

Endpoints is a top-tier network of clinical research centers in Latin America. We lead the way in delivering high-quality clinical, epidemiological, and public health research, helping transform science into real health solutions.

With 100+ trials completed, 50,000+ participants enrolled, and partnerships with 30+ global sponsors, our network is powered by 400+ experts across 9 centers of excellence in Panama, Colombia, and Guatemala.

Our Network

Therapeutic Focus

Infectious Diseases and Vaccines

COVID-19, RSV, Dengue, Poliovirus, Norovirus, Influenza, Pneumococcus, Chikungunya, HIV, Meningitis, Hepatitis A, Herpesvirus, HPV, Pertussis, Varicella, Zika Virus, others.

Cardiology

Hypertension, Dyslipidemia, Heart failure, Arrhythmias, Post-acute MI, Devices.

Endocrinology and Metabolism

Diabetes, Obesity, Other Hormonal Disorders.

Neurology and Psychiatry

Depression, Epilepsy, Migraine, Alzheimer’s Disease, Parkinson’s Disease.

Experience
Snapshot

100+
Clinical Trials

50,000+
Participants

30+
Sponsors and CROs

400+
Experts

9
Clinical Research Centers

<4%
Drop-Off Rate

We are
LATAM´s Benchmark

Faster, smarter feasibility through advanced data tools.

Centralized start-up and streamlined site activation.

A single point of contact for seamless collaboration.

Networked centers, aligned on quality and process.

Our Network

Proven Impact

We’ve helped develop 15+ approved vaccines, collaborated with WHO, NIH, and top pharma companies, and consistently delivered on quality, with zero critical audit findings, including from the FDA.

Astrazeneca Hillevax MSD Clover GSK moderna janssen Bristol Myers Squibb Alios Novartis novocuff Pfizer Takeda Urevac Sanofi RiverMark vaxxinity icon ppd iqvia vaxtrials syneos st jude's children hospital universidad del valle statens serum institut universidad de panama university of connecticut ministerio de salud de panama international vaccine institute panamerican health organization path fundacion valle de lili cdc yale universita di siena oms nationwide childrens acin cideim bill and melinda gates foundation cincinnati childrens hospital epidriver early bird clinica imbanaco fidec gorgas grid europe iact Astrazeneca Hillevax MSD Clover GSK moderna janssen Bristol Myers Squibb Alios Novartis novocuff Pfizer Takeda Urevac Sanofi RiverMark vaxxinity icon ppd iqvia vaxtrials syneos st jude's children hospital universidad del valle statens serum institut universidad de panama university of connecticut ministerio de salud de panama international vaccine institute panamerican health organization path fundacion valle de lili cdc yale universita di siena oms nationwide childrens acin cideim bill and melinda gates foundation cincinnati childrens hospital epidriver early bird clinica imbanaco fidec gorgas grid europe iact

Our Strategic Drivers

Innovation

AI & data science power our research engine.

Excellence

GCP standards, optimized operations, high-integrity data.

Reach

Expanding across Latin America through site and population intelligence.

Knowledge

KOL partnerships, education, and robust epidemiological insight.

Growth

Diversified portfolios, strategic positioning, and knowledge sharing.

Our Core Values

Transforming Science Into Real Solutions for Health

Ethics

Innovation

Empathy

Commitment

Solidarity

Respect